New CEO and CTO appointed at Rejuve – Information Age

AI-powered longevity research network Rejuve has announced the appointments of Jasmine Smith and Dr Deborah Duong as new CEO and CTO

The SingularityNET spinoff aims to extend the human health span with the aid of voluntarily donated medical data.

The new leadership team at Rejuve will help make the venture commercially available through the Longevity App, which will soon be available on iPhone and Android, allowing users to improve their health span while earning rewards for discounted healthcare products.

Decentralised network Rejuve is a spinoff of SingularityNET, which allows users to create, share, and monetise AI services at scale.

The company aims to extend the human health span as much as possible through research based on voluntarily donated medical data.

Data will be securely tracked through blockchain, with contributors retaining ownership of medical information as well as being granted compensation for supplying data in the form of tokens, redeemable for supplements, DNA test kits or longevity therapies.

New Rejuve CEO Jasmine Smith previously served for years as a community moderator in the SingularityNET ecosystem, her main focus being on transitioning Rejuve from an early-stage research initiative to a commercially available service.

As the new CEO, Smith will be responsible for ensuring growth of the community of data contributors, whose biodata will provide essential information for Rejuves longevity research.

Here is a list of the top chief executive and chief executive officer (CEO) appointments announced throughout tech. Read here

Following the appointment, Smith said: Longevity science is on the edge of amazing breakthroughs, with more funding and research than ever before.

However, longevity research should be a communal endeavour and not a perk for the privileged few. To ensure this, retaining ownership of the medical data we produce is crucial.

Too often, these data are siphoned and sold off before the contributors know it, without them seeing a reward. Longevity programs based on decentralised ownership of medical data, such as Rejuve, are the only way to ensure that the results of longevity research stay open, accessible and decentralised.

Dr Deborah Duong, an AI researcher focusing on computational social science, complex adaptive systems (CAS) and coevolutionary computation, will continue development of a tokenonomy based on non-fungible tokens (NFTs) that guarantee unconditional ownership of products by data and IP donors.

Dr Duong is currently researching emergent social phenomena among AI agents that generate data-driven casual models, as well as blockchain token economics that incentivise social good, bringing 30 years of experience in AI and CAS simulation to Rejuve ten of which have been in healthcare.

Below is a list of the biggest senior technology hires, including chief technology officer (CTO) and chief information officer (CIO) appointments. Read here

I envision the Rejuve ecosystem as the first true economy that uses the principles of decentralised AI to harness the power of social networks into scientific solutions to aging, new Rejuve CTO Duong commented.

This will be possible through a collaboration between decentralised AI and member stakeholders, incentivised to contribute through a just autonomous organisation that guarantees they own the fruits of their labour.

See the original post:
New CEO and CTO appointed at Rejuve - Information Age